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Abstract 
Background: Acute cholecystitis sometimes displays symptoms and electrocardiographic changes mimicking car-
diovascular problems. It may also coexist with cardiovascular disorders. We analyzed the clinical characteristic of the 
cardiac patients who were diagnosed with acute cholecystitis during hospitalization in the cardiology department.
Methods: Using the department database, we identified 16 patients who were diagnosed with acute cholecystitis 
during the hospitalization in the cardiology department between June 2010 and June 2014.
Results: Five patients who were initially suspected to have cardiac problems (acute coronary syndrome, four 
patients; Adams-Stokes syndrome, one patient) owing to their symptoms were subsequently diagnosed with acute 
cholecystitis. Two of these patients showed electrocardiographic changes mimicking myocardial ischemia, and three 
tested positive for a biomarker (heart-type fatty acid binding protein) of acute myocardial injury. The 11 remaining 
cardiac patients were diagnosed with acute cholecystitis during their hospitalization or at the time of admission. Pro-
longed fasting and/or staying in an intensive care unit (ICU) may have contributed to their condition. Among these 11 
patients, aortic dissection was the most prevalent underlying cardiac condition, affecting 5 patients.
Conclusions: Although it is a rare condition, acute cholecystitis may coexist with or be misdiagnosed as a cardiovas-
cular disorder. This possibility should not be overlooked in cardiac patients because a delay in treatment may result in 
critical complications.
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Background
Due to the similarity of symptoms, it is sometimes dif-
ficult to make a differential diagnosis between a biliary 
system disease, such as acute cholecystitis, and cardio-
vascular disorders [1–3]. Although the exact mecha-
nisms are poorly understood, laboratory data mimicking 
cardiovascular disease, such as elevation of cardiac tro-
ponin [4] and changes in electrocardiogram (ECG) data 
suggestive of ischemic heart disease [1, 5], may also 
occur among patients with cholecystitis. It should also be 
noted that acute cholecystitis may occur among cardiac 
patients because congestive heart failure [6], long stays in 
an intensive care unit [7], and prolonged after a cardio-
vascular event [8] may enhance the risk of cholecystitis. 
We herein analyzed the clinical characteristics of patients 
who were diagnosed with acute cholecystitis during hos-
pitalization in a cardiology department.
Methods
Study population
The study was approved by Ethics Committee at the 
Osaka Medical College. Between June 2010 and June 
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2014, 5552 patients were admitted to the cardiology 
department of Osaka Medical College. From the data-
base, we identified 18 patients who were diagnosed with 
acute cholecystitis during their hospitalization in the car-
diology department. Of these 18 patients, 2 patients did 
not have symptoms suggestive of de novo occurrence or 
worsening of cardiovascular conditions. After exclud-
ing these two patients, the remaining 16 patients were 
divided into two groups as follows: group 1 included 5 
patients who were initially diagnosed with cardiac condi-
tions, and in whom the signs and symptoms were actually 
due to cholecystitis; group 2 included 11 patients who 
were admitted with a cardiac condition and cholecystitis 
developed during their hospitalization or coexisted at the 
time of admission.
Laboratory analysis
Blood samples were generally taken after an overnight fast; 
however, for patients admitted in an emergency, this might 
have not been the case. Blood data were obtained when 
considered to be clinically necessary, and the baseline val-
ues and the peak values during the hospitalization regard-
ing to the hepatobiliary data (aspartate transaminase, 
γ-glutamyl transpeptidase, alkaline phosphatase, Total 
bilirubin) and markers indicating the extent of inflamma-
tion (white blood cell count and C-reactive protein), in 
particular, were demonstrated in the table. Positivity for 
heart-type fatty acid-binding protein (H-FABP) was exam-
ined by point-of-care-testing for H-FABP using Rapicheck 
H-FABP (Wakunaga Pharmaceutical, Osaka, Japan).
Diagnosis of acute cholecystitis
Acute cholecystitis was diagnosed by imaging modalities 
that were performed owing to suspected accompanying 
clinical symptoms such as fever and abdominal pain, and 
abnormalities in hepatobiliary and/or inflammatory labo-
ratory data. All patients underwent computed tomography 
(CT) and/or ultrasonography (US) that showed typical find-
ings indicating this diagnosis, such as gallbladder distension, 
gallbladder wall thickening and a trilaminar appearance or 
biliary calculus [9]. The diagnosis of cholecystitis was made 
or confirmed by gastroenterology physicians.
Results
Symptoms and initial diagnosis in group 1
The symptoms and past cardiovascular histories of the 
patients who were initially diagnosed with cardiac con-
ditions, but who actually had cholecystitis (group 1) are 
shown in Tables  1 and 2, and their laboratory data on 
admission and during hospitalization in the cardiology 
department are shown in Table 3.
Of the five patients in group 1, four (80 %) were initially 
suspected to have acute coronary syndrome owing to a sen-
sation of chest oppression (cases 1–4). Coronary angiogra-
phy ruled out a coronary artery event in cases 1, 2, and 3, 
and it did not any significant coronary artery stenosis in 
these patients. Coronary angiography was not performed in 
case 4 because a non-cardiac event was suspected due to the 
elevation of hepatobiliary enzymes. The remaining patient 
(case 5), who claimed loss of consciousness, was initially 
suspected to have had an Adams-Stokes attack because of a 
3-second pulse pause when the emergency services arrived.
Among the four patients suspected of acute coronary 
syndrome, two (cases 1, 2) showed ECG changes sug-
gestive of myocardial ischemia (Figs. 1, 2), while one did 
not have ECG changes (case 4). Case 3 had pacemaker 
rhythm; therefore, ST-T changes could not be assessed. 
Three of the four patients who were initially suspected 
Table 1 Characteristics of  patients initially diagnosed with  cardiac conditions but  found to  have acute cholecystitis 
(group 1)
ACS acute coronary syndrome, H-FABP heart-type fatty acid-binding protein
#01 #02 #03 #04 #05
Symptoms Chest oppression, 
dyspnea
Chest oppression Chest pain Chest oppression Loss of consciousness
Initial diagnosis  
(suspected)
ACS ACS ACS ACS Adams-Stokes attack
ECG changes  
on admission
Inverted or flat  
T in V2-6
ST depression  




Troponin T Negative Negative Negative Negative N/A
H-FABP Positive Negative Positive Positive N/A
Diagnosis interval, day 1 1 0 0 1
Cholelithiasis 0 1 0 1 1
Choledocholithiasis 0 0 0 1 0
Treatment Laparoscopic  
cholecystectomy
Cholecystectomy Antibiotics Endoscopic nasobiliary 
drainage
Cholecystectomy
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to have acute coronary syndrome tested positive for 
H-FABP, although cardiac troponin was negative. Renal 
function in all patients with a positive H-FABP test was 
within the normal range.
Inversion of the terminal T in precordial leads and 
V4was observed at the time of admission in case 1 (Fig. 1, 
arrows). This change was not observed in ECG that was 
taken 5 days afterward. In case 2, ST segment depression 
was noted in leads II, III, and aVF (Fig. 2, arrows), but this 
disappeared after 10 h.
Symptoms and initial diagnosis in group 2 and timing 
of the development of cholecystitis
The 11 patients in group 2 were admitted to the cardi-
ology department with true cardiovascular conditions 
(Tables 2, 3, 4). The most prevalent diagnosis was aortic 
dissection: three patients were in the acute phase and 
one was in the chronic phase. The second most prevalent 
diagnosis was congestive heart failure.
It was found that 5 (45  %) of the 11 patients who 
developed cholecystitis had a recent history of stay in 
the ICU before the occurrence of cholecystitis. Two 
patients (cases 12 and 14) were diagnosed to have chol-
ecystitis at the time of hospitalization in the cardiology 
department. One of them (case 14) had undergone end-
ovascular vascular repair (coil embolization for inter-
nal iliac artery aneurysm) at the cardiothoracic surgery 
department and was staying in ICU. Because the patient 
was known to have coronary artery lesions, she was 
transferred to the cardiology department at post-oper-
ative day 12; at this time point, the patient had elevated 
hepatobiliary data (AST, 300 IU/L; Al-P 2086 IU/L) and 
was diagnosed to have cholecystitis. Another patient 
(case 12) was admitted to the cardiology department 
due to worsening of congestive heart failure, for which 
inflammation of the gallbladder was thought to aggra-
vate the condition.
Two other patients were diagnosed with cholecystitis 
within a week of admission to the cardiology department 
(cases 8 and 16). Case 8 was diagnosed with cholecysti-
tis on the fourth day of admission. This patient had been 
an in-patient for 12 days at another hospital until 2 days 
before their admission to our hospital. In case 16, chol-
ecystitis was incidentally found by abdominal CT; an ele-
vation in transaminase levels was not observed before the 
diagnosis, and the patient was treated by antibiotics and 
parenteral alimentation. Six (55 %) of the 11 patients in 
group 2 did not have any oral intake for ≥3 days, and five 
patients had been staying in ICU.
Treatments
Among all 16 patients, 2 were treated with antibiot-
ics, and the remaining 14 required invasive treatments 
including gallbladder resection (Tables  1, 4). In some 
patients, gallbladder drainage prior to the cholecystec-
tomy was performed.
Discussion
We identified 16 patients who were diagnosed with chol-
ecystitis during hospitalization in the cardiology depart-
ment. Among two patients, in which acute coronary 
syndrome was initially suspected, ECG changes sugges-
tive of myocardial ischemia were observed. In eleven 
patients, in whom indeed had cardiovascular problems 
existed, eventually experienced gallbladder inflamma-
tion during hospitalization or at the time of admission. 
Fourteen patients (88 %) required cholecystectomy and/
or gallbladder drainage for the treatment of cholecystitis.
Table 2 Gender, age, and body structure of study patients
P values are meant for the difference between group 1 and group 2
Variables Group 1, n = 5 Group 2, n = 11
Women/men 1/4 2/9
Age, years 74.4 ± 8.6 73.5 ± 8.9
Height, m 1.62 ± 0.14 1.63 ± 0.08
Weight, kg 65.4 ± 12.0 62.0 ± 11.0
Body mass index, kg/m2 25.0 ± 3.5 23.1 ± 3.2
Table 3 Baseline and peak hepatobiliary data and inflam-
mation markers during  hospitalization in  the cardiology 
department
Numbers of patients for whom there were not data for the following parameters. 
Data on admission; r-GTP 2 patients in group 1, 1 patient in group 2, Al-p 2 
patients in group 1, 1 patient in group 2, CRP 1 patient in group 1. Peak data in 
the cardiology department: r-GTP 1 patient in group 1, Al-p 1 patient in group 1, 
CRP 1 patient in group 1
Variables Group 1,  
n = 5
Group 2,  
n = 11
On admission
 White blood cell count, ×103/mL 9.4 (3.3–20.7) 9.3 (5.8–14.8)
 Aspartate transaminase, IU/L 198 (25–293) 23 (17–81)
 Alanine transaminase, IU/L 51 (24–182) 25 (14–46)
 γ-Glutamyl transpeptidase, IU/L 87 (23–301) 78 (29–208)
 Alkaline phosphatase, IU/L 205 (189–333) 273 (170–418)
 Total bilirubin, mg/dL 0.7 (0.6–1.0) 0.8 (0.6–1.1)
 C-reactive protein, mg/dL 0.10 (0.04–3.71) 3.09 (0.54–5.94)
Peak values during hospitalization in Cardiology Department
 White blood cell count, ×103/mL 14.2 (3.5–23.9) 9.3 (7.3–15.5)
 Aspartate transaminase, IU/L 283 (34–314) 150 (34–300)
 Alanine transaminase, IU/L 54 (38–182) 67 (38–263)
 γ-Glutamyl transpeptidase, IU/L 202 (50–592) 218 (33–461)
 Alkaline phosphatase, IU/L 206 (193–302) 536 (261–1099)
 Total bilirubin, mg/dL 1.3 (0.7–2.5) 1.7 (0.7–2.7)
 C-reactive protein, mg/dL 8.85 (1.32–13.80) 6.94 (4.89–13.03)
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It is well known that not only chest symptoms but also 
ECG changes suggestive of myocardial ischemia might 
be present in patients with cholecystitis, such as T-wave 
inversion, ST segment depression, and ST segment ele-
vation [2, 10]. In addition to their confusing symptoms 
and ECG changes, H-FABP—a biochemical diagnostic 
marker in the early phase of acute myocardial infarction 
[11]—was positive in three (75  %) of four patients who 
were initially suspected to have acute coronary syndrome 
in group 1. H-FABP is known to be expressed also in 
non-cardiac organs, and it is elevated in non-cardiac dis-
orders such as pulmonary embolism, and hepatic injury 
[12]. In addition, the H-FABP test, as well as cardiac tro-
ponin T, may show false-positive results in subjects with 
reduced renal function owing to its lower renal clearance 
[13, 14], but all three patients with positive H-FABP test 
had normal range renal function. All 3 patients with a 
positive H-FABP result, the cardiac troponin T test was 
negative. A previous case report showed elevation of tro-
ponin I and creatinine kinase levels in a patient who had 
acute cholecystitis but normal coronary arteries [4]. To 
the best of our knowledge, the present paper is the first 
to demonstrate that an H-FABP test may be positive in 
patients with cholecystitis.
In the patients in group 2, acute cholecystitis coexisted 
or developed with true cardiovascular problems. This 
might be just co-incidental; however, there were several 

























Fig. 1 Electrocardiogram of case 1. Left On the admission. Right Five days after the admission. Changes of T wave (flat T, terminal T wave inversion) 

























Fig. 2 Electrocardiogram of case 2. Left On the admission. Right Ten hours after the admission. Note that ST segment depression seen in the ECG at 
the time of admission disappeared after 10 h
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First, heart failure might worsen in the presence of gall-
bladder inflammation, which may have been the case for 
two patients (case 12 and 16). Second, acute cholecystitis 
can occur in critically ill patients. For, example, Laurila 
et  al. reported that 39 (1  %) of 3984 patients staying in 
ICU developed acalculous cholecystitis [15]. In the cur-
rent study, cholecystitis developed in five patients after 
or while staying on the ICU; although two cases were 
calculous.
The ECG changes associated with acute cholecystitis, 
when present at all, may resolve either after cholecys-
tectomy or after a few days of antibiotic treatment [10]. 
Although the mechanisms by which acute cholecystitis 
causes ECG changes remain unclear, several possibilities 
have been suggested. First, distention of the bile duct may 
actually reduce the coronary artery flow [16, 17]. Sec-
ond, there may be a coronary vasospasm that is caused 
by a vagally mediated reflex [2]. ECG changes may also 
be evoked in response to inflammation of other visceral 
organs; for instance, Rubio-Tapia reported that more 
than half of their study patients with acute pancreatitis 
showed certain ECG abnormalities, some of which might 
reflect electrolyte alterations and dehydration [18]. Fur-
thermore, Yamazaki et al. reported a 53-year-old woman 
with chronic hepatitis C who showed ECG changes that 
mimicked myocardial ischemia [19].
There are several limitations in the current study. First, 
cardiac patients in general do not undergo screening by 
abdominal CT/US even in the presence of mild hepato-
biliary data abnormalities; therefore, clinically silent or 
less severe cholecystitis might have been overlooked. 
Second, patients who experienced acute cholecystitis 
after their discharge were not counted. These conditions 
may have led to an underestimation of the prevalence of 
cholecystitis among in-patients in the cardiology depart-
ment. Third, retrospective nature of the study. Subjects 
who have both cardiovascular disorders and acute chole-
cystitis might be found if we perform more complete sur-
vey by the prospective study. Fourth, small sample size 
of the study. We were unable to statistically demonstrate 
the patient characteristics that are more prone to be mis-
diagnosed to have cardiovascular disease. Fifth, incom-
pleteness of the surveillance of the hepatobiliary system. 
The diagnosis was in general made by gastroenterolo-
gist; however, those with acute cholecystitis who had 
only mild or subclinical symptoms may not be diagnosed 
with cholecystitis because we did not decide to consult 
gastroenterologists.
Conclusions
Among 5552 patients who were admitted to the cardiol-
ogy department at our institute, we identified 16 patients 
who were diagnosed with acute cholecystitis during 
hospitalization—five patients who were initially suspected 
to have cardiovascular disease, which was later turned 
out not to be correct, and the remaining 11 patients 
were found to have both acute cholecystitis and cardio-
vascular diseases. Patients with acute cholecystitis may 
demonstrate, albeit rarely, ECG changes and laboratory 
abnormalities (such as positive H-FABP) that are sugges-
tive of coronary ischemia; however, considering that we 
could diagnosed acute cholecystitis within 1 day after the 
admission, careful physical examination as well as routine 
laboratory tests of the hepatobiliary systems may able to 
avoid the delay of diagnosis of this gastroenterological 
disorder that might cause critical complications.
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